Anticocaine catalytic antibodies have no affinity for RTI compounds: Implications for treatment
- 14 May 2001
- Vol. 41 (2) , 176-178
- https://doi.org/10.1002/syn.1072
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pharmacotherapies for Treatment of Cocaine Abuse: Preclinical AspectsJournal of Medicinal Chemistry, 1999
- RTI-113 administration reduces cocaine self-administration at high occupancy of dopamine transporterSynapse, 1998
- A catalytic antibody against cocaine prevents cocaine’s reinforcing and toxic effects in ratsProceedings of the National Academy of Sciences, 1998
- Active Immunization with Cocaine–Protein Conjugate Attenuates Cocaine EffectsPharmacology Biochemistry and Behavior, 1997
- Suppression of psychoactive effects of cocaine by active immunizationNature, 1995
- Reinforcing and discriminative stimulus effects of β-CIT in rhesus monkeysPharmacology Biochemistry and Behavior, 1995
- Antibody-Catalyzed Degradation of CocaineScience, 1993
- A potential vaccine for cocaine abuse prophylaxisImmunopharmacology, 1992
- Self-administration of the high-affinity cocaine analog 2β-carbomethoxy-3β-(4-fluorophenyl)tropanePharmacology Biochemistry and Behavior, 1991
- Changes in heroin self-administration by a rhesus monkey after morphine immunisationNature, 1974